Valproic acid sodium-induced spina bifida occulta in the rat

Neurosurgical Review

Volumn 24, Issue 1, 2001, Pages 31-34

  Ceylan, S ^a,a,b   Duru, S ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b Kou Medical Faculty   (Turkey)

Author keywords

Neural tube defects (NTD); Rat; Side effects; Spina bifida occulta; Valproic acid sodium

Indexed keywords

SODIUM CHLORIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; EXENCEPHALY; FEMALE; FETUS; GESTATIONAL AGE; MALE; NEURAL TUBE; NEURAL TUBE DEFECT; NEUROEPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SACRAL SPINAL CORD; SPINA BIFIDA; TERATOGENICITY; THORACIC SPINE; VERTEBRA;

EID: 0034847377     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011963     Document Type: Article

References (19)

1. Valproic acid and spina bifida
2. Prenatal ultrasonographic diagnosis in the epileptic mother on valproic acid. Retrospective study of 161 cases in the central eastern France register of congenital malformations
3. Arnold-Chiari-like malformation associated with a valproate model of spina bifida in the rat
4. Marked accumulation of valproic acid in embyonic neuroepithelium of the mouse during early organogenesis
5. Valproic acid-induced spina bifida: A mouse model
6. Teratogenicity of valproic acid: In vivo and in vitro investigations
7. Possible teratogenic effect of valproate during pregnancy
8. Spina bifida and in utero exposure to valproate
9. In utero exposure to valproate and neural tube defects
10. Spectrum of neural tube defects in 34 infants prenatally exposed to anti-epileptic drugs
11. Teratogenic valproic acid concentrations: Infusion by implanted minipumps vs. conventional injection regimen in the mouse
12. Valproic acid teratogenesis
13. Valproic acid and its metabolites: Placental transfer, neonatal pharmacokinetics, transfer via mother's milk, and clinical status in neonates of epileptic mothers
14. Valproic acid-induced neural tube defects in mouse and human aspects of chirality alternative drug development pharmacokinetics and possible mechanisms
15. The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort
16. The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: Effect of dose comedication and the presence of spina bifida
17. Valproate and birth defects
18. Teratogenic effects on the neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate
19. A procedure for differential staining of cartilage and bone in whole formaline-fixed vertebrates